Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 3, 2012, Pages 905-913

  Colombo, Carla ^a   Verga, Uberta ^b   Mian, Caterina ^c   Ferrero, Stefano ^a,b   Perrino, Michela ^a   Vicentini, Leonardo ^b   Dazzi, Davide ^d   Opocher, Giuseppe ^e   Pelizzo, Maria Rosa ^c   Beck Peccoz, Paolo ^a,b   Fugazzola, Laura ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d Ospedale di Fidenza   (Italy)

^e VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; GLUCONATE CALCIUM; PARATHYROID HORMONE; PENTAGASTRIN;

ABDOMINAL CRAMP; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER REGRESSION; CELL HYPERPLASIA; CHILD; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DRUG INDUCED HEADACHE; FEMALE; FOLLOW UP; GENE; GENE MUTATION; HEAT SENSATION; HIGH CALCIUM TEST; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NAUSEA; NODULAR GOITER; PARESTHESIA; PENTAGASTRIN TEST; PRESCHOOL CHILD; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RET GENE; SCHOOL CHILD; SIDE EFFECT; STOMACH PAIN; THROAT TIGHTNESS; THYROID MEDULLARY CARCINOMA; URINARY URGENCY;

ADOLESCENT; ADULT; AGED; CALCITONIN; CALCIUM; CARCINOMA, MEDULLARY; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MIDDLE AGED; PENTAGASTRIN; REPRODUCIBILITY OF RESULTS; THYROID NEOPLASMS; THYROID NODULE;

EID: 84858039688     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-2033     Document Type: Article

References (30)

1. Modigliani E, Cohen R, Campos JM, Conte-Devolx B, Maes B, Boneu A, Schlumberger M, Bigorgne JC, Dumontier P, Leclerc L, Corcuff B, Guilhem I 1998 Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. Clin Endocrinol (Oxf) 48:265-273 (Pubitemid 28137636)
2. Schlumberger M, Carlomagno F, Baudin E, Bidart JM, Santoro M 2008 New therapeutic approaches to treat medullary thyroid carcinoma. Nat Clin Pract Endocrinol Metab 4:22-32 (Pubitemid 350291115)
3. Elisei R, Pinchera A, Romei C, Gryczynska M, Pohl V, Maenhaut C, Fugazzola L, Pacini F 1994 Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab 78:867-871
4. Iacobone M, Niccoli-Sire P, Sebag F, De Micco C, Henry JF 2002 Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels. World J Surg 26:886-890 (Pubitemid 36920281)
5. Elisei R, Bottici V, Luchetti F, Di Coscio G, Romei C, Grasso L, Miccoli P, Iacconi P, Basolo F, Pinchera A, Pacini F 2004 Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. J Clin Endocrinol Metab 89:163-168 (Pubitemid 38183876)
6. Vierhapper H, Niederle B, Bieglmayer C, Kaserer K, Baumgartner-Parzer S 2005 Early diagnosis and curative therapy of medullary thyroid carcinoma by routine measurement of serum calcitonin in patients with thyroid disorders. Thyroid 15:1267-1272 (Pubitemid 41821761)
7. Costante G, Meringolo D, Durante C, Bianchi D, Nocera M, Tumino S, Crocetti U, Attard M, Maranghi M, Torlontano M, Filetti S 2007 Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J Clin Endocrinol Metab 92:450-455
8. Rink T, Truong PN, Schroth HJ, Diener J, Zimny M, Grünwald F 2009 Calculation and validation of a plasma calcitonin limit for early detection of medullary thyroid carcinoma in nodular thyroid disease. Thyroid 19:327-332
9. Chambon G, Alovisetti C, Idoux-Louche C, Reynaud C, Rodier M, Guedj AM, Chapuis H, Lallemant JG, Lallemant B 2011 The use of preoperative routine measurement of basal serum thyrocalcitonin in candidates for thyroidectomy due to nodular thyroid disorders: results from 2733 consecutive patients. J Clin Endocrinol Metab 96: 75-81
10. Elisei R 2008 Routine serum calcitonin measurement in the evaluation of thyroid nodules. Best Pract Res Clin Endocrinol Metab 22:941-953
11. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W; European Thyroid Cancer Taskforce 2006 European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787-803
12. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, Hauger BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214
13. Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedüs L, Vitti P; AACE/AME/ETA Task Force on Thyroid Nodules 2010 American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. J Endocrinol Invest 33(5 Suppl):1-50
14. American Thyroid Association Guidelines Task Force, Kloos RT, Eng C, Evans DB, Francis GL, Gagel RF, Gharib H, Moley JF, Pacini F, Ringel MD, Schlumberger M, Wells Jr SA 2009 Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 19:565-612
15. Wells Jr SA, Baylin SB, Linehan WM, Farrell RE, Cox EB, Cooper CW 1978 Provocative agents and the diagnosis of medullary carcinoma of the thyroid gland. Ann Surg 188:139-141 (Pubitemid 8396759)
16. Gharib H, Kao PC, Heath 3rd H 1987 Determination of silicapurified plasma calcitonin for the detection and management of medullary thyroid carcinoma: comparison of two provocative tests. Mayo Clin Proc 62:373-378 (Pubitemid 17098344)
17. Kudo T, Miyauchi A, Ito Y, Yabuta T, Inoue H, Higashiyama T, Tomoda C, Hirokawa M, Amino N 2011 Serum calcitonin levels with calcium loading tests before and after total thyroidectomy in patients with thyroid diseases other than medullary thyroid carcinoma. Endocr J 58:217-221
18. Doyle P, Düren C, Nerlich K, Verburg FA, Grelle I, Jahn H, Fassnacht M, Mäder U, Reiners C, Luster M 2009 Potency and tolerance of calcitonin stimulation with high-dose calcium vs. pentagastrin in normal adults. J Clin Endocrinol Metab 94:2970-2974
19. Verga U, Ferrero S, Vicentini L, Brambilla T, Cirello V, Muzza M, Beck-Peccoz P, Fugazzola L 2007 Histopathological and molecular studies in patients with goiter and hypercalcitoninemia: reactive or neoplastic C-cell hyperplasia? Endocr Relat Cancer 14:393-403 (Pubitemid 47242638)
20. Albores-Saavedra J, Monforte H, Nadji M, Morales AR 1988 C-cell hyperplasia in thyroid tissue adjacent to follicular cell tumors. Hum Pathol 19:795-799
21. Perry A, Molberg K, Albores-Saavedra J 1996 Physiologic versus neoplastic C-cell hyperplasia of the thyroid. Cancer 77:750-756
22. Kaserer K, Scheuba C, Neuhold N, Weinhäusel A, Haas OA, Vierhapper H, Niederle B 2001 Sporadic versus familial medullary thyroid microcarcinoma: a histopathologic study of 50 consecutive patients. Am J Surg Pathol 25:1245-1251 (Pubitemid 32917117)
23. Matias-Guiu X, DeLellis R, Moley JF, Gagel RF, Albores-Saavedra J, Bussolati G, Kaserer K, Williams ED, Baloch Z 2004 Tumors of the thyroid: medullary thyroid carcinoma. In: De Lellis RA, Lloyd RV, Heitz PU, Eng C, eds. World Health Organization classification of tumours. Tumours of endocrine organs. Lyon: IARC Press
24. American Joint Committee on Cancer 2002 TNM classification of malignant tumours. In: Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, Morrow M, eds. AJCC cancer staging handbook. 6th ed. Chap 8. New York: Verlag; 89-98
25. LiVolsi VA 1997 C cell hyperplasia/neoplasia. J Clin Endocrinol Metab 82:39-41
26. Machens A, Hoffmann F, Sekulla C, Dralle H 2009 Importance of gender-specific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer. Endocr Relat Cancer 16:1291-1298
27. Scheuba C, Kaserer K, Moritz A, Drosten R, Vierhapper H, Bieglmayer C, Haas OA, Niederle B 2009 Sporadic hypercalcitoninemia: clinical and therapeutic consequences. Endocr Relat Cancer 16: 243-253
28. d'Herbomez M, Caron P, Bauters C, Do Cao C, Schlienger JL, Sapin R, Baldet L, Carnaille B, Wémeau JL 2007 Reference range of serum calcitonin levels in humans: influence of calcitonin assays, sex, age, and cigarette smoking. Eur J Endocrinol 157:749-755
29. Karges W, Dralle H, Raue F, Mann K, Reiners C, Grussendorf M, Hüfner M, Niederle B, Brabant G, German Society for Endocrinology (DGE)-Thyroid Section 2004 Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation. Exp Clin Endocrinol Diabetes 112:52-58
30. Vierhapper H, Raber W, Bieglmayer C, Kaserer K, Weinhäusl A, Niederle B 1997 Routine measurement of plasma calcitonin in nodular thyroid diseases. J Clin Endocrinol Metab 82:1589-1593 (Pubitemid 27200439)